Natural products research: Perspectives from a major pharmaceutical company

Journal of Ethnopharmacology

Volumn 51, Issue 1-3, 1996, Pages 29-38

  Borris, Robert P ^a  

^a MERCK RESEARCH LABORATORIES   (United States)

Author keywords

Biodiversity; Drug discovery; Natural products

Indexed keywords

NATURAL PRODUCT;

CONFERENCE PAPER; DRUG INDUSTRY; DRUG ISOLATION; DRUG SCREENING; MICROORGANISM; NONHUMAN; PHYTOCHEMISTRY;

EID: 0029883967     PISSN: 03788741     EISSN: None     Source Type: Journal    
DOI: 10.1016/0378-8741(95)01347-4     Document Type: Conference Paper

References (3)

1. Alberts, A.W., Chen, J., Kuron, G., Hunt, V., Huff, J., Hoffman, C., Rothrock, J., Lopez, M., Joshua, H., Harris, E., Patchett, A.A., Monaghan, R., Currie, S., Stapley, E.O., Albers-Schonberg, G., Hensens, O.D., Hirschfield, J.M., Hoogsteen, K., Liesch, J. and Springer, J.P. (1980) Mevinolin, a highly potent competitive inhibitor of HMG-CoA reductase and cholesterol lowering agent. Proceedings of the National Academy of Sciences (USA) 77, 3957-3961.
2. Miller, T.W., Chaiet, L., Cole, D.J., Cole, L.J., Flor, J.E., Goegelman, R.T., Gullo, V.P., Joshua, H., Kempf, A.J., Krellwitz, W.R., Monaghan, R.L., Ormond, R.E., Wilson, K.E., Albers-Schonberg, G. and Putter, I. (1979) Avermectins, a new family of potent anthelminthic agents: isolation and Chromatographic properties. Antimicrobial Agents and Chemotherapy 15, 368-371.
3. US Congress, Office of Technology Assessment. (1993) Pharmaceutical R & D Costs, Risks and Rewards. Washington DC: U.S Government Printing Office (OTA-H-522).